PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 3266683

Bleeding colonic varices controlled by propranolol.

L G McAlpine·G G Birnie·T E Hilditch·J H Dagg
View original source ↗Export metadata ↓

Abstract

A 64-year-old man with hepatic cirrhosis developed severe haemorrhage from oesophageal varices. He underwent a course of sclerotherapy injections which successfully obliterated the oesophageal varices and prevented further oesophageal bleeding. He later developed serious bleeding from a site in the region of the ascending colon; angiography and radionuclide imaging suggested that varices were present in that region. Therapy with oral propranolol was effective in preventing any recurrence of gastrointestinal bleeding.

Explore related subjects

Colonic DiseasesEsophageal and Gastric VaricesGastrointestinal HemorrhageHumansLiver Cirrhosis, AlcoholicMaleMiddle AgedPortal VeinPropranololCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L G McAlpine, G G Birnie, T E Hilditch, J H Dagg. 1988. Bleeding colonic varices controlled by propranolol.. https://doi.org/10.1177/003693308803300608

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2012

Crohn's disease.

Crohn's disease is a relapsing systemic inflammatory disease, mainly affecting the gastrointestinal tract with extraintestinal manifestations and associated immune disorders. Genome wide association studies identified susceptibility loci that--triggered by environmental factors--result in a disturbed innate (ie, disturbed intestinal barrier, Paneth cell dysfunction, endoplasmic reticulum stress, defective unfolded protein response and autophagy, impaired recognition of microbes by pattern recognition receptors, such as nucleotide binding domain and Toll like receptors on dendritic cells and macrophages) and adaptive (ie, imbalance of effector and regulatory T cells and cytokines, migration and retention of leukocytes) immune response towards a diminished diversity of commensal microbiota. We discuss the epidemiology, immunobiology, amd natural history of Crohn's disease; describe new treatment goals and risk stratification of patients; and provide an evidence based rational approach to diagnosis (ie, work-up algorithm, new imaging methods [ie, enhanced endoscopy, ultrasound, MRI and CT] and biomarkers), management, evolving therapeutic targets (ie, integrins, chemokine receptors, cell-based and stem-cell-based therapies), prevention, and surveillance.

Colonic Diseases↗